Research ArticleMinireview
Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection
Omid Tavassoly, Farinaz Safavi and Iman Tavassoly
Molecular Pharmacology November 2020, 98 (5) 612-619; DOI: https://doi.org/10.1124/molpharm.120.000098
Omid Tavassoly
Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada (O.T.); Neuroimmunology and Neurovirology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (F.S.); and Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, New York (I.T.)
Farinaz Safavi
Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada (O.T.); Neuroimmunology and Neurovirology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (F.S.); and Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, New York (I.T.)
Iman Tavassoly
Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada (O.T.); Neuroimmunology and Neurovirology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (F.S.); and Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, New York (I.T.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMinireview
Heparin-binding Peptides for the Treatment of SARS-CoV-2
Omid Tavassoly, Farinaz Safavi and Iman Tavassoly
Molecular Pharmacology November 1, 2020, 98 (5) 612-619; DOI: https://doi.org/10.1124/molpharm.120.000098
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement